CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.

Roda, Julie M

CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Aug 2005 - 1619-27 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.

0022-1767

10.4049/jimmunol.175.3.1619 doi


Adjuvants, Immunologic--pharmacology
Adoptive Transfer
Animals
Antibodies, Monoclonal--metabolism
Antibodies, Monoclonal, Humanized
Cell Line, Tumor
Cells, Cultured
CpG Islands--immunology
Cytokines--biosynthesis
Cytotoxicity, Immunologic--immunology
DNA-Binding Proteins--biosynthesis
Female
Humans
Immunoglobulin G--administration & dosage
Interferon-gamma--biosynthesis
Killer Cells, Natural--immunology
Mice
Mice, Inbred BALB C
Neoplasm Transplantation
Oligodeoxyribonucleotides--administration & dosage
Receptors, Cell Surface--biosynthesis
Toll-Like Receptor 9
Trastuzumab